Get started
KOACT US CNS THERAPEUTICS ACTIVEKOACT US CNS THERAPEUTICS ACTIVEKOACT US CNS THERAPEUTICS ACTIVE

KOACT US CNS THERAPEUTICS ACTIVE

No trades
See on Supercharts
Overview
Analysis Holdings Discussions Technicals Seasonals

490330 chart


Full chart

Key stats


Assets under management (AUM)
‪5.90 B‬ KRW
Fund flows (1Y)
‪−2.88 B‬ KRW
Dividend yield (indicated)
—
Discount/Premium to NAV
0.3%
Shares outstanding
‪700.00 K‬
Expense ratio
0.50%

About KOACT US CNS THERAPEUTICS ACTIVE


Issuer
SAMSUNG LIFE INSURANCE
Brand
KoAct
Home page
samsungactive.co.kr
Inception date
Sep 3, 2024
Management style
Active
Primary advisor
Samsung Active Asset Management Co., Ltd.
ISIN
KR7490330008
The fund is actively managed ETF that seeks to outperform the daily performance of Solactive US CNS Therapeutics index by mainly investing in U.S. listed companies related to CNS Therapeutics.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Health care equipment & services
Strategy
Active
Geography
U.S.
Weighting scheme
Proprietary
Selection criteria
Proprietary

490330 analysis


What's in the fund
Exposure type
StocksBonds, Cash & Other
Health Technology
Stock breakdown by region
83%16%
Top 10 holdings

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Broaden your horizons with more funds linked to 490330 via country, focus, and more.